---
document_datetime: 2023-09-21 17:04:49
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tecfidera-epar-all-authorised-presentations_en.pdf
document_name: tecfidera-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8855391
conversion_datetime: 2025-12-19 23:20:21.387494
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form            | Route of Administration   | Immediate Packaging             | Content (concentration)   | Pack size    |
|------------------|-------------------|------------|--------------------------------|---------------------------|---------------------------------|---------------------------|--------------|
| EU/1/13/837/001  | TECFIDERA         | 120 mg     | Gastro-resistant capsule, hard | Oral use                  | blister (PVC/PE/PVDC - PVC alu) |                           | 14 capsules  |
| EU/1/13/837/002  | TECFIDERA         | 240 mg     | Gastro-resistant capsule, hard | Oral use                  | blister (PVC/PE/PVDC - PVC alu) |                           | 56 capsules  |
| EU/1/13/837/003  | TECFIDERA         | 240 mg     | Gastro-resistant capsule, hard | Oral use                  | blister (PVC/PE/PVDC - PVC alu) |                           | 168 capsules |